We are live on ! Find out more

1,970 hedge funds and large institutions have $146B invested in Pfizer in 2015 Q4 according to their latest regulatory filings, with 195 funds opening new positions, 801 increasing their positions, 756 reducing their positions, and 80 closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more first-time investments, than exits

New positions opened: 195 | Existing positions closed: 80

5% more funds holding

Funds holding: 1,8801,970 (+90)

1.41% more ownership

Funds ownership: 75.71%77.11% (+1.4%)

6% more repeat investments, than reductions

Existing positions increased: 801 | Existing positions reduced: 756

4% more capital invested

Capital invested by funds: $140B → $146B (+$6.18B)

5% less funds holding in top 10

Funds holding in top 10: 267253 (-14)

39% less call options, than puts

Call options by funds: $1.79B | Put options by funds: $2.95B

Holders
1,970
Holders Change
+90
Holders Change %
+4.79%
% of All Funds
51.67%
Holding in Top 10
253
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-5.24%
% of All Funds
6.64%
New
195
Increased
801
Reduced
756
Closed
80
Calls
$1.79B
Puts
$2.95B
Net Calls
-$1.16B
Net Calls Change
-$1.83B
Name Holding Trade Value Shares
Change
Change in
Stake
GW
1126
GW & Wade
Massachusetts
$1.92M +$150K +4,773 +8%
AssetMark Inc
1127
AssetMark Inc
California
$1.92M +$1.41M +44,900 +253%
LCM
1128
Leisure Capital Management
California
$1.92M +$29.2K +927 +2%
UAS
1129
United Asset Strategies
New York
$1.92M +$4.59K +146 +0.2%
DAM
1130
Doheny Asset Management
California
$1.91M
MFW
1131
Meristem Family Wealth
Minnesota
$1.91M
MBA
1132
McQueen Ball & Associates
Pennsylvania
$1.91M +$1.96M +62,426 New
SA
1133
Strategic Advisors
New York
$1.91M -$1.57M -49,844 -44%
RP
1134
Rowlandmiller & Partners
Georgia
$1.91M +$11.9K +378 +0.6%
WDA
1135
Wendell David Associates
New Hampshire
$1.9M -$27.7K -882 -1%
BFIM
1136
Beese Fulmer Investment Management
Ohio
$1.9M +$66.3K +2,108 +4%
NFG
1137
Next Financial Group
Texas
$1.9M -$40.3K -1,282 -2%
SFSG
1138
Stearns Financial Services Group
North Carolina
$1.9M -$7.61K -242 -0.4%
Jane Street
1139
Jane Street
New York
$1.9M +$1.6M +50,999 +466%
DI
1140
Diligent Investors
California
$1.89M -$27.2K -864 -1%
HCM
1141
Hutchinson Capital Management
California
$1.89M +$9.85K +313 +0.5%
CHJWM
1142
Carlton Hofferkamp & Jenks Wealth Management
Texas
$1.89M +$33.2K +1,055 +2%
SPC
1143
Stewart & Patten Company
California
$1.86M +$14.9K +474 +0.8%
WFG
1144
Wills Financial Group
Virginia
$1.85M +$406K +12,890 +27%
HH
1145
Hilltop Holdings
Texas
$1.85M +$35.7K +1,134 +2%
WA
1146
WFG Advisors
Texas
$1.85M -$56.5K -1,796 -3%
DWA
1147
Douglass Winthrop Advisors
New York
$1.85M -$743K -23,613 -28%
IWMPD
1148
Integrated Wealth Management (Palm Desert)
California
$1.84M -$109K -3,455 -5%
GF
1149
Gerstein Fisher
New York
$1.84M -$174K -5,518 -8%
SAM
1150
Strategy Asset Managers
California
$1.82M +$19K +604 +1%

PFE Hedge Fund Activity: Q4 2015 in Review

1,970 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q4 2015, worth a combined $146B — up 4.4% from $140B a quarter earlier.

Buyers outnumbered sellers: 195 funds opened new PFE positions and 80 closed out — a net gain of 115 holders — while 801 added to existing stakes and 756 trimmed.

The largest buyer was Deutsche Bank, adding an estimated $604M. The largest seller was Capital World Investors, cutting an estimated $1.47B.

  • 1,970 institutional investors held Pfizer (PFE) as of Q4 2015, up from 1,880 in Q3 2015.
  • Funds reported $146B of Pfizer stock for Q4 2015, up 4.4% quarter-over-quarter.
  • 195 funds opened new Pfizer positions in Q4 2015 and 80 closed out, a net change of +115 holders.
  • The largest Pfizer buyer in Q4 2015 was Deutsche Bank, an estimated $604M added.
  • The largest Pfizer seller in Q4 2015 was Capital World Investors, an estimated $1.47B sold.

Based on aggregated 13F filings for Q4 2015.